TransDigm
TDG
1,096.21
-7.12
-0.65%
TransDigm
US · TDG
#361 by market cap
Listed 1970
1,096.21
-7.12
-0.65%
Live - 5344 symbols - heartbeat 503s ago
· 2026-10-08 07:40
Pre-market
1,096.21
0.00%
After-hours
1,096.21
0.00%
- Market cap
- 60.59B
- P/E (TTM)i
- 33.25
- P/Bi
- -6.18
- EPSi
- 32.08
- Div yieldi
- 0.00%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on TDG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.71, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.22% YoY
Margins
- Gross margin
- 60.14%
- Operating margin
- 47.44%
- Net margin
- 21.13%
Key ratios & quality
- Enterprise valuei
- 87.82B
- PEG ratioi
- 0.98
- Altman Z-Scorei
- 1.71
PEG uses trailing P/E against the 3-year net income growth rate (33.79%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.81B | 5.22B | 5.10B | 4.80B | 5.43B | 6.59B | 7.94B | 8.83B |
| Gross profit | 2.18B | 2.81B | 2.65B | 2.51B | 3.10B | 3.84B | 4.67B | 5.31B |
| Selling & admin expenses | 450.00M | 748.00M | 727.00M | 685.00M | 748.00M | 780.00M | 934.00M | 921.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.66B | 1.93B | 1.75B | 1.69B | 2.22B | 2.92B | 3.58B | 4.19B |
| Pretax profit | 986.00M | 1.06B | 740.00M | 715.00M | 1.13B | 1.72B | 2.22B | 2.63B |
| Tax | 24.00M | 222.00M | 87.00M | 34.00M | 261.00M | 417.00M | 500.00M | 555.00M |
| Net profit | 957.00M | 892.00M | 700.00M | 681.00M | 867.00M | 1.30B | 1.72B | 2.07B |
| Basic EPS | 16 | 14 | 9 | 10 | 13 | 22 | 26 | 32 |
| Diluted EPS | 16.20 | 13.84 | 8.96 | 10.41 | 13.40 | 22.03 | 25.62 | 32.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.15B | 2.24B | 2.44B | 2.29B | 2.54B | 2.74B |
| Gross profit | 1.27B | 1.33B | 1.47B | 1.35B | 1.51B | 1.63B |
| Selling & admin expenses | 231.00M | 236.00M | 248.00M | 249.00M | 264.00M | 312.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 996.00M | 1.05B | 1.17B | 1.05B | 1.19B | 1.25B |
| Pretax profit | 622.00M | 635.00M | 753.00M | 572.00M | 700.00M | 713.00M |
| Tax | 143.00M | 142.00M | 144.00M | 127.00M | 164.00M | 173.00M |
| Net profit | 479.00M | 493.00M | 609.00M | 445.00M | 536.00M | 540.00M |
| Basic EPS | 8 | 8 | 8 | 7 | 9 | 9 |
| Diluted EPS | 8.24 | 8.47 | 7.75 | 6.62 | 9.20 | 9.39 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.66B | 4.87B | 6.96B | 7.03B | 5.65B | 6.74B | 10.03B | 7.01B |
| Cash & ST investments | 2.07B | 1.47B | 4.72B | 4.79B | 3.00B | 3.47B | 6.26B | 2.81B |
| Inventory | 805.29M | 1.23B | 1.28B | 1.19B | 1.33B | 1.62B | 1.88B | 2.10B |
| Total assets | 12.20B | 16.26B | 18.40B | 19.32B | 18.11B | 19.97B | 25.59B | 22.91B |
| Total current liabilities | 900.38M | 1.54B | 1.62B | 1.66B | 1.43B | 1.58B | 6.34B | 2.18B |
| Short-term debt | 375.34M | 430.00M | 647.00M | 646.00M | 444.00M | 436.00M | 603.00M | 863.00M |
| Long-term debt | 12.50B | 16.47B | 19.38B | 19.37B | 19.37B | 19.33B | 24.30B | 29.17B |
| Total liabilities | 14,005,938,000.00 | 19,139,000,000.00 | 22,363,000,000.00 | 22,225,000,000.00 | 21,873,000,000.00 | 21,948,000,000.00 | 31,869,000,000.00 | 32,588,000,000.00 |
| Total equity | -1.81B | -2.88B | -3.97B | -2.91B | -3.77B | -1.98B | -6.28B | -9.68B |
| Retained earnings | -2.25B | -3.12B | -4.36B | -3.71B | -3.91B | -2.62B | -7.36B | -10.61B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.41B | 6.92B | 7.01B | 6.97B | 8.58B | 7.77B |
| Cash & ST investments | 2.43B | 2.79B | 2.81B | 2.53B | 3.88B | 2.77B |
| Inventory | 2.01B | 2.08B | 2.10B | 2.37B | 2.40B | 2.59B |
| Total assets | 21.91B | 22.70B | 22.91B | 23.76B | 25.44B | 26.75B |
| Total current liabilities | 2.07B | 2.21B | 2.18B | 2.54B | 2.44B | 2.57B |
| Short-term debt | 743.00M | 744.00M | 863.00M | 849.00M | 853.00M | 864.00M |
| Long-term debt | 24.31B | 24.27B | 29.17B | 29.20B | 31.15B | 32.62B |
| Total liabilities | 27,569,000,000.00 | 27,696,000,000.00 | 32,588,000,000.00 | 33,020,000,000.00 | 34,836,000,000.00 | 36,473,000,000.00 |
| Total equity | -5.66B | -5.00B | -9.68B | -9.26B | -9.39B | -9.72B |
| Retained earnings | -6.41B | -5.92B | -10.61B | -10.17B | -9.64B | -9.11B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.02B | 1.02B | 1.21B | 913.00M | 948.00M | 1.38B | 2.05B | 2.04B |
| Depreciation & amortization | 129.00M | 226.00M | 283.00M | 253.00M | 253.00M | 268.00M | 312.00M | 367.00M |
| Free cash flow | 949.00M | 913.00M | 1.11B | 808.00M | 829.00M | 1.24B | 1.88B | 1.82B |
| Dividends paid | -56.00M | -1.71B | -1.93B | -73.00M | -1.09B | -38.00M | -2.04B | -9.63B |
| Stock buybacks / issuance | 0 | 0 | -19.00M | 0 | -912.00M | 0 | 0 | -500.00M |
| Ending cash balance | 2.07B | 1.47B | 4.72B | 4.79B | 3.00B | 3.47B | 6.26B | 2.81B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 148.00M | 631.00M | 507.00M | 832.00M | 135.00M | 724.00M |
| Depreciation & amortization | 89.00M | 92.00M | 96.00M | 100.00M | 105.00M | 119.00M |
| Free cash flow | 92.00M | 573.00M | 441.00M | 772.00M | 64.00M | 650.00M |
| Dividends paid | 0 | 0 | -5.23B | -59.00M | 0 | 0 |
| Stock buybacks / issuance | -53.00M | -131.00M | 0 | -106.00M | -615.00M | -1.09B |
| Ending cash balance | 2.43B | 2.79B | 2.81B | 2.53B | 3.88B | 2.77B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | 8.13 | 5.47 | 2.97 | 3.22 | 4.17 | 6.62 | 6.50 | 7.70 |
| ROIC %i | -- | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 43.26 | 36.81 | 34.67 | 36.97 | 40.58 | 43.74 | 44.09 | 47.57 |
| FCF / sales %i | 24.90 | 17.50 | 21.71 | 16.84 | 15.27 | 18.77 | 23.68 | 20.56 |
| Current ratioi | 4.06 | 3.16 | 4.31 | 4.23 | 3.96 | 4.27 | 1.58 | 3.21 |
| Quick ratioi | 3.08 | 1.65 | 3.36 | 3.35 | 2.78 | 2.98 | 1.21 | 2.03 |
| Debt / assetsi | 105.57 | 103.96 | 108.89 | 103.64 | 109.42 | 98.98 | 97.31 | 131.08 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 2.49 | 2.24 | 1.72 | 1.68 | 2.05 | 2.47 | 2.72 | 2.67 |
| Revenue CAGR (3Y) %i | 12.08 | 18.09 | 13.35 | 7.98 | 1.30 | 8.87 | 18.28 | 17.61 |
| Net income CAGR (3Y) %i | 28.86 | 14.92 | 5.41 | -10.77 | -0.91 | 22.91 | 36.09 | 33.79 |
| FCF CAGR (3Y) %i | 26.75 | 12.61 | 15.57 | -5.22 | -3.17 | 3.71 | 32.51 | 29.87 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 7.91 | 7.86 | 7.70 | 7.99 | 7.87 | 7.73 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 46.07 | 46.34 | 47.57 | 46.66 | 46.67 | 46.27 |
| FCF / sales %i | 22.66 | 22.21 | 20.56 | 20.61 | 19.47 | 19.26 |
| Current ratioi | 3.09 | 3.13 | 3.21 | 2.75 | 3.52 | 3.02 |
| Quick ratioi | 1.86 | 1.95 | 2.03 | 1.61 | 2.30 | 1.78 |
| Debt / assetsi | 114.35 | 110.19 | 131.08 | 126.47 | 125.79 | 125.16 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 2.73 | 2.66 | 2.67 | 2.55 | 2.50 | 2.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Power & Control is the largest reported line at 55.05% of revenue, across 3 reported segments.
- Airframe follows at 43.27%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Power & Control55.05%
Airframe43.27%
Non-aviation1.68%
Quote time 2026-10-08 07:40:08 · For reference only, not investment advice and not tailored to your situation.